Abstract:Abstract Background 6-Gingerol (6-G) is the primary active phytocomponent of ginger and has been shown to regulate multiple targets against cancer and its treatment. Androgen receptors (ARs) remain critical in the progression of prostate cancer (PCa). This study focuses on investigating 6-G as a promising anti-cancerous agent that inhibits AR activity significantly. Methods In this study, molecular docking simulation was done to investigate the binding affinity of 6-G and control drug Bicalutamide (BT) against oncogenic AR and tumor suppressor estrogen receptor β (ERβ). The crystal structure of AR and ERβ was retrieved from Protein Data Bank (PDB) and docked with 3D Pubchem structures of 6-G using iGEMDOCK and AutoDock. Further in vitro study was done to evaluate the antioxidant, anti-cancerous, apoptotic, and wound healing potential of 6-G. Results The result displays that 6-G shows good binding affinity with AR and ERβ. Condensation of the nucleus, change in mitochondrial membrane potential (MMP) and the ability to induce reactive oxygen species (ROS) were done in human PCa PC-3 cells. Results from the MTT assay demonstrated that 6-G and control drug BT showed significant ( p < 0.01) dose and time dependent inhibition of human PCa PC-3 cells. 6-G increased the ROS generation intracellularly and decreased the MMP, and cell migration in treated PCa PC-3 cells. 6-G treated cells showed fragmented, condensed chromatin and nuclear apoptotic bodies. Conclusions Thus, this study validates 6-G as a potential drug candidate against human PCa. However, further study of the anticancer potency of 6-G has to be done before its use for PCa treatment.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to evaluate the effect of 6 - Gingerol (6 - G) as a potential anticancer drug on human prostate cancer cells, especially its ability to inhibit the activity of androgen receptor (AR). Specifically, the study explored the binding affinity of 6 - G with AR and tumor suppressor estrogen receptor β (ERβ) through molecular docking simulation and in vitro experiments, and evaluated its antioxidant, anticancer, pro - apoptotic and wound - healing potential. ### Research Background - **Prostate Cancer**: Prostate cancer is the third leading cause of cancer death among elderly men worldwide. Androgen receptor plays a key role in the occurrence, invasion and progression of prostate cancer. - **Androgen Receptor**: Factors such as amplification of androgen receptor gene, gain - of - function mutations, oxidative stress and inflammation lead to an increase in AR expression. - **Estrogen Receptor**: Estrogen receptor α (ERα) plays a carcinogenic role in the progression and metastasis of prostate cancer, while estrogen receptor β (ERβ) has a tumor - suppressive effect. - **Treatment Status**: At present, the main methods for treating prostate cancer include castration therapy, anti - androgen drugs and AR antagonists. However, these treatment methods are often accompanied by side effects, and the cancer may recur and progress to the metastatic stage. ### Research Objectives - **Evaluate the Anticancer Potential of 6 - Gingerol**: Through molecular docking simulation and in vitro experiments, evaluate the antioxidant, anticancer, pro - apoptotic and wound - healing effects of 6 - Gingerol on human prostate cancer cells (PC - 3 cells). - **Explore the Binding Affinity of 6 - Gingerol with AR and ERβ**: Through molecular docking simulation, study the binding mode and affinity of 6 - Gingerol with AR and ERβ. ### Methods - **Molecular Docking Simulation**: Use iGEMDOCK and AutoDock software for molecular docking simulation to evaluate the binding affinity of 6 - Gingerol with AR and ERβ. - **In Vitro Experiments**: - **Cell Viability Assay**: Use the MTT method to evaluate the inhibitory effect of 6 - Gingerol on PC - 3 cells. - **Reactive Oxygen Species (ROS) Generation**: Detect the generation of ROS in cells after 6 - Gingerol treatment by fluorescence microscopy. - **Mitochondrial Membrane Potential (MMP) Change**: Use MitoTracker dye to detect the MMP change of cells after 6 - Gingerol treatment. - **Nuclear Condensation**: Use DAPI staining to observe the nuclear morphological changes of cells after 6 - Gingerol treatment. - **Cell Apoptosis**: Use Acridine Orange/Propidium Iodide double - staining method to detect cell apoptosis. - **Wound - Healing Experiment**: Evaluate the effect of 6 - Gingerol on the migration ability of PC - 3 cells. - **Cell Cycle Analysis**: Analyze the cell cycle distribution of cells after 6 - Gingerol treatment by flow cytometry. ### Results - **Molecular Docking Results**: 6 - Gingerol shows good binding affinity with AR and ERβ. - **In Vitro Experiment Results**: - 6 - Gingerol significantly inhibits the growth of PC - 3 cells in a dose - and time - dependent manner. - 6 - Gingerol increases the generation of ROS in cells, decreases MMP and inhibits cell migration. - Cells treated with 6 - Gingerol show characteristics of nuclear condensation and cell apoptosis. ### Conclusions - This study shows that 6 - Gingerol is a potential candidate drug for prostate cancer treatment, which can effectively inhibit AR activity, induce cell apoptosis and reduce cell migration. However, further research is still needed to verify its practical application potential in prostate cancer treatment.

Structure based docking and biological evaluation towards exploring potential anti-cancerous and apoptotic activity of 6-Gingerol against human prostate carcinoma cells

Potential Antitumor Effects of 6-Gingerol in p53-Dependent Mitochondrial Apoptosis and Inhibition of Tumor Sphere Formation in Breast Cancer Cells

In silico docking of phytocompounds to identify potent inhibitors of signaling pathways involved in prostate cancer

Effect of ginger, chamomile, and green tea extracts on prostate cancer cells

Investigating the bioactive compounds from Capsicum annum as a probable alternative therapy for prostate cancer treatment: a structure-based drug design approach

Exploration on natural product anibamine side chain modification toward development of novel CCR5 antagonists and potential anti-prostate cancer agents

1‐Dehydro‐6‐Gingerdione Exerts Anticancer Effects on MDA‐MB‐231 Cells and in the Xenograft Mouse Model by Promoting the Ferroptosis Pathway

Exploring the molecular targets and mechanisms of [10]-Gingerol for treating triple-negative breast cancer using bioinformatics approaches, molecular docking, and in vivo experiments

Assessing the antibacterial potential of 6-gingerol: Combined experimental and computational approaches

Anticancer Effects of 6-Gingerol through Downregulating Iron Transport and PD-L1 Expression in Non-Small Cell Lung Cancer Cells

6-Shogaol from ginger shows anti-tumor effect in cervical carcinoma via PI3K/Akt/mTOR pathway

Integrating network pharmacology approaches for the investigation of multi-target pharmacological mechanism of 6-shogaol against cervical cancer

Induction of apoptosis by [6]-gingerol associated with the modulation of p53 and involvement of mitochondrial signaling pathway in B[a]P-induced mouse skin tumorigenesis

Review of the anticancer properties of 6-shogaol: Mechanisms of action in cancer cells and future research opportunities

In Silico Study on the Interactions, Molecular Docking, Dynamics and Simulation of Potential Compounds from Withania somnifera (L.) Dunal Root against Cancer by Targeting KAT6A

Encapsulation of gingerol into nanoliposomes: Evaluation of in vitro anti‐inflammatory and anti‐cancer activity

Abstract A39: 6-Gingerol, a chemopreventive phytochemical as speed breaker in inflammatory and stress signaling cascade triggered by benzo(a)pyrene and dextran sulphate sodium-mediated colorectal cancer in mice

Epigallocatechin gallate and curcumin inhibit Bcl-2: a pharmacophore and docking based approach against cancer

Preparation and Evaluation of 6-Gingerol Derivatives as Novel Antioxidants and Antiplatelet Agents

Differentially Expressed Genes (DEGs) Analysis Indicating 6-Shogaol Anticancer Activity Against HCT-116 Cells Performed Primarily by Affecting Genes in Common (SHARED-DEGs) of Apoptotic and P53 Signaling Pathways

Effect and Mechanism of 6-Gingerol against Precancerous Lesions of Gastric Cancer Based on Network Pharmacology and In Vitro Experiment